Xuefeng Li

733 total citations
34 papers, 389 citations indexed

About

Xuefeng Li is a scholar working on Surgery, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Xuefeng Li has authored 34 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Surgery, 9 papers in Molecular Biology and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Xuefeng Li's work include Metabolism, Diabetes, and Cancer (5 papers), Peripheral Artery Disease Management (4 papers) and Diabetes Treatment and Management (4 papers). Xuefeng Li is often cited by papers focused on Metabolism, Diabetes, and Cancer (5 papers), Peripheral Artery Disease Management (4 papers) and Diabetes Treatment and Management (4 papers). Xuefeng Li collaborates with scholars based in China, United States and Belgium. Xuefeng Li's co-authors include Junwei Cai, Wenhong Cao, Zhenqi Liu, Longying Zha, Suxia Sun, Hong Deng, Limei Mao, Xinwei Chu, Fang Wang and Yijie Liu and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and Medicine.

In The Last Decade

Xuefeng Li

30 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xuefeng Li China 10 138 113 64 63 50 34 389
Lisette Bok Netherlands 8 145 1.1× 116 1.0× 20 0.3× 59 0.9× 59 1.2× 8 463
Qingsong Tao China 12 147 1.1× 153 1.4× 38 0.6× 91 1.4× 74 1.5× 30 464
Chenyang Wang China 13 193 1.4× 160 1.4× 41 0.6× 20 0.3× 58 1.2× 43 516
Yunzhi Chen China 12 68 0.5× 108 1.0× 49 0.8× 40 0.6× 79 1.6× 59 425
Jesús García‐Bañuelos Mexico 14 70 0.5× 157 1.4× 59 0.9× 62 1.0× 175 3.5× 28 544
Wesam A. Nasif Egypt 12 79 0.6× 76 0.7× 36 0.6× 23 0.4× 82 1.6× 32 367
William Yip Canada 6 87 0.6× 152 1.3× 76 1.2× 41 0.7× 145 2.9× 8 427
Chikako Tokoro Japan 10 237 1.7× 262 2.3× 42 0.7× 57 0.9× 60 1.2× 24 591
Jonas Sieber United States 10 106 0.8× 171 1.5× 53 0.8× 92 1.5× 123 2.5× 12 585
Guiping Li China 12 68 0.5× 113 1.0× 22 0.3× 48 0.8× 68 1.4× 55 475

Countries citing papers authored by Xuefeng Li

Since Specialization
Citations

This map shows the geographic impact of Xuefeng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuefeng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuefeng Li more than expected).

Fields of papers citing papers by Xuefeng Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuefeng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuefeng Li. The network helps show where Xuefeng Li may publish in the future.

Co-authorship network of co-authors of Xuefeng Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xuefeng Li. A scholar is included among the top collaborators of Xuefeng Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuefeng Li. Xuefeng Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xiang, Qun, et al.. (2025). Chemerin as a biomarker of inflammatory bowel diseases: a meta-analysis. BMC Gastroenterology. 25(1). 662–662.
2.
3.
Zhang, Lijuan, Zhidong Liu, Chunhua Liu, et al.. (2024). Ten-day vonoprazan–amoxicillin dual therapy versus 14-day esomeprazole–amoxicillin dual therapy for first-line Helicobacter pylori eradication: a prospective multicenter randomized controlled trial. Therapeutic Advances in Gastroenterology. 17. 1118492846–1118492846. 2 indexed citations
4.
Zhang, Zhengwei, Xuefeng Li, Jie Liu, et al.. (2023). FUNDC1 modulates mitochondrial defects and pancreatic β-cell dysfunction under lipotoxicity. Biochemical and Biophysical Research Communications. 672. 54–64. 8 indexed citations
5.
Wang, Jizhou, Wei Wu, Dehao Huang, et al.. (2022). Incidence of Ischemia Reperfusion Injury Related Biliary Complications in Liver Transplantation: Effect of Different Types of Donors. Transplantation Proceedings. 54(7). 1865–1873. 6 indexed citations
6.
7.
Zheng, Hao, Ning Wang, Xuefeng Li, et al.. (2021). An Orthotopic Liver Transplantation Patient Survived Without Hepatic Artery Flow Due to Thrombosis: A Case Report. Transplantation Proceedings. 53(4). 1295–1299. 3 indexed citations
8.
Li, Xuefeng, et al.. (2021). Comparison of clinical outcomes and spino-pelvic sagittal balance in degenerative lumbar spondylolisthesis. Medicine. 100(3). e23783–e23783. 26 indexed citations
9.
Li, Xuefeng, et al.. (2020). Association between Interleukin‐10 Gene Polymorphisms and Behcet’s Disease Susceptibility: Evidence from a Meta‐Analysis. Journal of Immunology Research. 2020(1). 9382609–9382609. 1 indexed citations
10.
Li, Xuefeng, et al.. (2019). Min-invasive surgical treatment for multiple axis fractures: A case report. World Journal of Clinical Cases. 7(7). 898–902. 2 indexed citations
11.
Niu, Yu‐Ming, Yadong Wang, Guangbin Jiang, et al.. (2019). Association Between Vitamin D Receptor Gene Polymorphisms and Polycystic Ovary Syndrome Risk: A Meta-Analysis. Frontiers in Physiology. 9. 1902–1902. 20 indexed citations
12.
Zhou, Wuhua, Xuefeng Li, Yunyan Wan, et al.. (2018). Screening key candidate genes and pathways involved in insulinoma by microarray analysis. Medicine. 97(22). e10826–e10826. 6 indexed citations
13.
Zha, Longying, Suxia Sun, Limei Mao, et al.. (2014). Soyasaponins Can Blunt Inflammation by Inhibiting the Reactive Oxygen Species-Mediated Activation of PI3K/Akt/NF-kB Pathway. PLoS ONE. 9(9). e107655–e107655. 109 indexed citations
14.
Yang, Xuefeng, Shuang Mei, Haihua Gu, et al.. (2014). Exposure to excess insulin (glargine) induces type 2 diabetes mellitus in mice fed on a chow diet. Journal of Endocrinology. 221(3). 469–480. 18 indexed citations
15.
Mei, Shuang, Xuefeng Yang, Haihua Gu, et al.. (2014). A Small Amount of Dietary Carbohydrate Can Promote the HFD-Induced Insulin Resistance to a Maximal Level. PLoS ONE. 9(7). e100875–e100875. 9 indexed citations
16.
Guo, Lianrui, et al.. (2013). Plaque excision in the management of lower-limb ischemia of atherosclerosis and in-stent restenosis with the SilverHawk atherectomy catheter.. PubMed. 32(4). 362–7. 6 indexed citations
17.
Wang, Fang, et al.. (2012). Increased circulating myostatin in patients with type 2 diabetes mellitus. Journal of Huazhong University of Science and Technology [Medical Sciences]. 32(4). 534–539. 35 indexed citations
18.
Li, Xuefeng, Xiaowei Liu, Yi-You Zou, et al.. (2010). Predictors of Clinical and Endoscopic Findings in Differentiating Crohn’s Disease from Intestinal Tuberculosis. Digestive Diseases and Sciences. 56(1). 188–196. 42 indexed citations
19.
Liu, Xiaowei, et al.. (2010). Screening of clinical and endoscopic parameters for differentiating Crohn’s disease from intestinal tuberculosis by logistic regression analysis. World Chinese Journal of Digestology. 18(6). 621–621. 3 indexed citations
20.
Li, Xuefeng, et al.. (2008). Polymorphism of apolipoprotein A5 is a risk factor for cerebral infarction in type 2 diabetes. Journal of Huazhong University of Science and Technology [Medical Sciences]. 28(6). 653–656. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lisette Bok Breakdown of academic impact, for papers by Qingsong Tao Breakdown of academic impact, for papers by Chenyang Wang Breakdown of academic impact, for papers by Yunzhi Chen Breakdown of academic impact, for papers by Jesús García‐Bañuelos Breakdown of academic impact, for papers by Wesam A. Nasif Breakdown of academic impact, for papers by William Yip Breakdown of academic impact, for papers by Chikako Tokoro Breakdown of academic impact, for papers by Jonas Sieber Breakdown of academic impact, for papers by Guiping Li
Rankless by CCL
2026